J Korean Gastric Cancer Assoc.  2005 Sep;5(3):158-162.

Clinical Correlation between the Serum Pepsinogen I/II Ratio and Gastric Cancer

Affiliations
  • 1Department of Surgery, CHA University, Seongnam, Korea. dhahn@cha.ac.kr
  • 2Department of Pathology, CHA University, Seongnam, Korea.
  • 3Department of Preventive Medicine, CHA University, Seongnam, Korea.
  • 4Department of Internal Medicine, CHA University, Seongnam, Korea.

Abstract

PURPOSE
In order to clarify the carcinogenesis mechanism from chronic atrophic gastritis toward gastric cancer, we measured the pepsinogen I and II and compared their ratio with several clinical findings.
MATERIALS AND METHODS
We measured the preoperative serum pepsinogen I and II by using a radio-immunoassay and compared their ratio with several clinical findings, such as tumor size, mucinous vs non-mucinous tumor, cell differentiation, tumor location, depth of invasion, lymph-node status, Lauren's classification, and peritumoral atrophy in 103 consecutive patients with gastric adenocarcinomas who had received resections at Bundang CHA Hospital during the period from July 2003 to February 2005.
RESULTS
There were significant differences in the serum pepsinogen I/II ratio between patients with mucinous vs non-mucinous tumors (n=4 vs 9 and mean pep I/II=1.29 vs. 2.99, P=0.0288), with tumor size more than and less than 10 cm2 (n=55 vs. 48 and mean pep I/II=2.64 vs. 3.24, P=0.0491), and with or without peritumoral atrophy (n=94 vs. 9 and mean pep I/II=2.83 vs. 3.89, P=0.0466). In patients with peritomoral atrophy, the pepsinogen I/II ratio was also lower in larger tumors (n=48 vs. 46 and mean pep I/II=2.44 vs. 3.23, P=0.0083). Well-differentiated carcinomas showed significantly lower serum pep I/II ratios than signet-ring-cell types. There was no correlation between serum pep I/II ratio and tumor location, depth of invasion, lymph-node status, or Lauren's classification.
CONCLUSION
We proved the existence of a correlation between serum pepsinogen level and musosal atrophy, but these results are not sufficient for clinical application of serum pepsinogen level as a screening tool for gastric cancer.

Keyword

Gastric adenocarcinoma; Pepsinogen; Atrophic gastritis

MeSH Terms

Adenocarcinoma
Atrophy
Carcinogenesis
Cell Differentiation
Classification
Gastritis, Atrophic
Humans
Mass Screening
Mucins
Pepsinogen A*
Stomach Neoplasms*
Mucins
Pepsinogen A
Full Text Links
  • JKGCA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr